Khashayar Dashtipour

Featured in: Favicon

mdpi.com

neurologylive.com

Articles

Treatment Options for Spasticity

Jul 10, 2024 | neurologylive.com | Khashayar Dashtipour |Francois Bethoux |Jennifer Smith

July 10, 2024By A panel of experts discuss treatment options available for spasticity as well as when patients should be treated with pharmacological options. Discuss treatment options available for spasticity. How is spasticity managed upon initial clinical presentation? When should patients be treated with pharmacological options? Surgical options? Botulinum toxin (BT) injections are used widely to treat focal spasticity. When and in which patients are BT injections recommended?
Designing Spasticity Treatment Based on Patient Goals

Jul 2, 2024 | neurologylive.com | Khashayar Dashtipour |Francois Bethoux |Jennifer Smith

Designing Spasticity Treatment Based on Patient GoalsThe panel evaluates the merits of tailoring treatment plans to address either patient goals, such as muscle tone relaxation and functional improvements, or caregiver objectives. Do you recommend designing treatment plans based on patient goals (relaxation of muscle tone, functional gain, etc.) or caregiver goals? Please explain.
Impact of Spasticity of Patient and Caregiver’s Quality of Life

Jul 2, 2024 | neurologylive.com | Khashayar Dashtipour |Francois Bethoux |Jennifer Smith

Impact of Spasticity of Patient and Caregiver’s Quality of LifeKey opinion leaders examine the short-term and long-term effects of spasticity on patients' and caregivers' quality of life. How does clinical presentation of moderate or severe spasticity change post-injury/insult (changes in joint movement, range of motion early vs later, etc.)?
Definition and Pathophysiology of Spasticity

Jun 20, 2024 | neurologylive.com | Khashayar Dashtipour |Francois Bethoux |Jennifer Smith

June 20, 2024Khashayar Dashtipour, MD, PhD; Francois Bethoux, MD; Jennifer Smith, PA, and Ye Vivian Liang, MD, PhD offer a comprehensive examination of the underlying mechanisms and physiological processes involved in spasticity. Spasticity can result from many health conditions or injuries. What is the most widely accepted definition of spasticity? How do you define moderate and severe spasticity? Describe underlying pathophysiology of spasticity. Related Content Related Content
Changes in Presentation of Spasticity Over Time

Jun 20, 2024 | neurologylive.com | Khashayar Dashtipour |Francois Bethoux |Jennifer Smith

June 20, 2024The expert panel examines the evolution of moderate to severe spasticity following injury or insult, focusing on alterations in joint mobility, changes in range of motion from early to later stages, and other progressive manifestations of the condition. How does clinical presentation of moderate or severe spasticity change post-injury/insult (changes in joint movement, range of motion early vs later, etc.)? Related Content Related Content
Ensuring Good Quality of Life With Good ON Time in Parkinson Disease: Khash Dashtipour, MD, PhD

Jun 9, 2023 | neurologylive.com | Khashayar Dashtipour

WATCH TIME: 5 minutesAt the 2nd Annual Advanced Therapeutics in Movement and Related Disorders (ATMRD) Congress, held by the PMD Alliance from June 8 to 11, 2023, in Washington, DC, a number of presenters offered insight into the concept of “good ON time” in Parkinson disease (PD). Generally, this is qualified as time a given patient is experiencing benefit from their medication without any related troublesome symptoms, such as dyskinesia.
Maximizing "On" Time: Longer-Lasting Levodopa Therapy Options for Parkinson's Disease

May 24, 2023 | neurologylive.com | Khashayar Dashtipour

Parkinson’s disease (PD) is a progressive neurodegenerative disorder.1 As the disease progresses, the therapeutic window of levodopa narrows, such that previously effective doses of levodopa no longer provide adequate motor symptom control without negative side effects.2,3 Disease severity and other factors are speculated to result in emerging or increasing motor complications, which consist of motor fluctuations between alternating states when motor symptoms are well-controlled by levodopa...